Global Retirement Partners’s Cogent Biosciences COGT Stock Holding History

Global Retirement Partners’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.13K	Buy	+210	New	+$7.35K	﹤0.01%	3494
2025 Q4	$37.1K	Buy	+1,045	New	+$29.4K	﹤0.01%	2529
2023 Q3	–	Sell	-121	Closed	-$1.43K	–	3266
2023 Q2	$1.43K	Sell	121 -1,201	-91%	-$13.8K	﹤0.01%	2660
2023 Q1	$15K	Hold	1,322	–	–	﹤0.01%	1763
2022 Q4	$15.3K	Sell	1,322 -500	-27%	-$6.2K	﹤0.01%	1597
2022 Q3	$25K	Hold	1,822	–	–	﹤0.01%	1285
2022 Q2	$16K	Hold	1,822	–	–	﹤0.01%	1435
2022 Q1	$8K	Hold	1,822	–	–	﹤0.01%	1698
2021 Q4	$16K	Hold	1,822	–	–	0.01%	128
2021 Q3	$15K	Hold	1,822	–	–	﹤0.01%	1293
2021 Q2	$15K	Hold	1,822	–	–	﹤0.01%	1269
2021 Q1	$16K	Buy	1,822 +121	+7%	+$1.17K	﹤0.01%	1165
2020 Q4	$19K	Buy	+1,701	New	+$18.7K	﹤0.01%	1044

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Global Retirement Partners's COGT Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Cogent Biosciences (COGT) in Q2 2026: 210 shares worth $8.13K. The stake represents ﹤0.01% of the portfolio and ranks #3494 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in COGT as recently as Q4 2025.

Global Retirement Partners first reported a position in COGT in Q4 2020 and has held it in 13 quarters since. The position peaked at $37.1K in Q4 2025. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

Global Retirement Partners held 210 shares of Cogent Biosciences worth $8.13K as of Q2 2026.
Cogent Biosciences was a new Global Retirement Partners position in Q2 2026.
Cogent Biosciences made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3494 holding.
Global Retirement Partners first reported a position in Cogent Biosciences in Q4 2020 and has held it in 13 quarters since.
Global Retirement Partners's Cogent Biosciences position peaked at $37.1K in Q4 2025.
323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.